Saa3em2Litt
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Saa3em2Litt |
| Name: |
serum amyloid A 3; endonuclease-mediated mutation 2, Dan R Littman |
| MGI ID: |
MGI:7717772 |
| Synonyms: |
SAATKO |
| Gene: |
Saa3 Location: Chr7:46361422-46365100 bp, - strand Genetic Position: Chr7, 30.51 cM
|
| Alliance: |
Saa3em2Litt page
|
|
| Strain of Origin: |
(C57BL/6NTac x 129S6/SvEvTac)F1
|
|
| Allele Type: |
|
Endonuclease-mediated (Null/knockout) |
| Mutation: |
|
Nucleotide substitutions
|
| |
|
Mutation details: CRISPR/Cas9 genome editing is used to introduce premature stop codons (TAG TAA), a frame shift mutation (A), and a HindIII site (AAGCTT) in to exon 2. Recombination was done using mice carrying Del(7Saa1-Saa2)1Itl creating triple knockout mice.
(J:296071)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Saa3 Mutation: |
22 strains or lines available
|
|
| Original: |
J:296071 Lee JY, et al., Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease. Cell. 2020 Jan 9;180(1):79-91.e16 |
| All: |
3 reference(s) |
|